DMAC · Healthcare · $449M
$8.27+0.85%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 463 Biotechnology peers
“이번 분기는 매출이 최근 4개 분기 연속 0달러로 상업화보다 임상 진전에 의미가 있는 분기예요.”
In the company's words · 2026 2분기 earnings call